What is happening in the pharmaceutical market of the EAEU and CIS countries today? Have the approaches to the formation of the regulatory strategy changed? What areas of development will be the most effective in 2023 in the current geopolitical conditions?
The Eurasian Pharmaceutical Forum will help you impartially assess the current situation and develop plans for the near future.
The forum provides an opportunity to meet the leading players of the pharmaceutical market - regulators, international and local pharmaceutical manufacturers, distributors and pharmacy chains - to discuss topical issues facing the industry today and predict further development.
PARTICIPATION WAS CONFIRMED BY:
|BAYER||AstraZeneca||Johnson & Johnson||Janssen||Adamed Pharma Kz|
|Haleon||Heel||Izvarino Pharma||Aristo Farma||Jurabek Laboratories|
|Livisto||Materia Medica Holding||Medisorb||MICROGEN||Novartis|
|Organon||Petrovax Pharm||POLYSAN||Queisser Pharma||Roche|
|Takeda||Teva||Valenta Pharm||Vita Pharmed SA||
|Dr. Reddy’s Laboratories Kazakhstan||Gedeon Richter||Gilead Sciences||Jadran||
|Acino||Amity International||Belpharmprom||Ferrer Kazakhstan||SK-Pharmacy|
Support of the leading industry associationsof the EAEU and CIS countries, provides a high level of expertise and deep understanding of the processes taking place in local markets
Effective networking formats - round tables with regulatory authorities, personal meetings with top managers of companies and, of course, opportunities for informal communication provided by the forum program